(LMT) Lockheed Martin - Overview
Sector: Industrials | Industry: Aerospace & Defense | Exchange: NYSE (USA) | Market Cap: 141.928m USD | Total Return: 39% in 12m
Avg Trading Vol: 885M USD
Peers RS (IBD): 71.9
EPS Trend: -30.6%
Qual. Beats: 0
Rev. Trend: 74.0%
Qual. Beats: 0
Lockheed Martin Corporation (LMT) is an aerospace and defense company. It researches, designs, develops, manufactures, integrates, and sustains technology systems, products, and services globally.
The company operates through four segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The defense sector is characterized by long development cycles and significant government contracts.
Aeronautics provides combat and air mobility aircraft. MFC offers air and missile defense systems and tactical missiles. RMS supplies military and commercial helicopters, surface ships, and various defense systems. The Space segment delivers satellites, space transportation systems, and national security systems. These segments highlight the diverse product offerings typical of major defense contractors.
LMT primarily serves the U.S. government, international customers, and foreign military sales. Understanding LMTs financial performance and market position requires further detailed analysis, which platforms like ValueRay can facilitate.
- Increased defense spending boosts Aeronautics and Missiles and Fire Control sales
- Geopolitical events drive demand for advanced defense systems globally
- Government contract awards secure long-term revenue streams
- Supply chain disruptions impact production and delivery schedules
| Net Income: 5.02b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 2.04 > 1.0 |
| NWC/Revenue: 2.70% < 20% (prev 3.42%; Δ -0.72% < -1%) |
| CFO/TA 0.14 > 3% & CFO 8.56b > Net Income 5.02b |
| Net Debt (17.58b) to EBITDA (8.73b): 2.01 < 3 |
| Current Ratio: 1.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (231.9m) vs 12m ago -2.15% < -2% |
| Gross Margin: 10.16% > 18% (prev 0.10%; Δ 1.01k% > 0.5%) |
| Asset Turnover: 130.0% > 50% (prev 127.7%; Δ 2.28% > 0%) |
| Interest Coverage Ratio: 6.30 > 6 (EBITDA TTM 8.73b / Interest Expense TTM 1.12b) |
| A: 0.03 (Total Current Assets 25.36b - Total Current Liabilities 23.34b) / Total Assets 59.84b |
| B: 0.23 (Retained Earnings 14.03b / Total Assets 59.84b) |
| C: 0.12 (EBIT TTM 7.04b / Avg Total Assets 57.73b) |
| D: 0.13 (Book Value of Equity 6.72b / Total Liabilities 53.12b) |
| Altman-Z'' Score: 1.94 = BBB |
| DSRI: 1.05 (Receivables 16.90b/15.31b, Revenue 75.06b/71.04b) |
| GMI: 0.97 (GM 10.16% / 9.88%) |
| AQI: 0.95 (AQ_t 0.43 / AQ_t-1 0.45) |
| SGI: 1.06 (Revenue 75.06b / 71.04b) |
| TATA: -0.06 (NI 5.02b - CFO 8.56b) / TA 59.84b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
Over the past week, the price has changed by -0.95%, over one month by -10.69%, over three months by +25.62% and over the past year by +39.00%.
- StrongBuy: 7
- Buy: 4
- Hold: 12
- Sell: 1
- StrongSell: 0
| ISSUER | TARGET | UP/DOWN |
|---|---|---|
| Wallstreet Target Price | 664.3 | 9.9% |
| Analysts Target Price | 664.3 | 9.9% |
P/E Forward = 20.4918
P/S = 1.8912
P/B = 21.1171
P/EG = 1.3137
Revenue TTM = 75.06b USD
EBIT TTM = 7.04b USD
EBITDA TTM = 8.73b USD
Long Term Debt = 20.53b USD (from longTermDebt, last quarter)
Short Term Debt = 1.17b USD (from shortTermDebt, last quarter)
Debt = 21.70b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 17.58b USD (from netDebt column, last quarter)
Enterprise Value = 159.51b USD (141.93b + Debt 21.70b - CCE 4.12b)
Interest Coverage Ratio = 6.30 (Ebit TTM 7.04b / Interest Expense TTM 1.12b)
EV/FCF = 23.09x (Enterprise Value 159.51b / FCF TTM 6.91b)
FCF Yield = 4.33% (FCF TTM 6.91b / Enterprise Value 159.51b)
FCF Margin = 9.20% (FCF TTM 6.91b / Revenue TTM 75.06b)
Net Margin = 6.68% (Net Income TTM 5.02b / Revenue TTM 75.06b)
Gross Margin = 10.16% ((Revenue TTM 75.06b - Cost of Revenue TTM 67.43b) / Revenue TTM)
Gross Margin QoQ = 11.47% (prev 12.04%)
Tobins Q-Ratio = 2.67 (Enterprise Value 159.51b / Total Assets 59.84b)
Interest Expense / Debt = 1.34% (Interest Expense 290.0m / Debt 21.70b)
Taxrate = 12.21% (187.0m / 1.53b)
NOPAT = 6.18b (EBIT 7.04b * (1 - 12.21%))
Current Ratio = 1.09 (Total Current Assets 25.36b / Total Current Liabilities 23.34b)
Debt / Equity = 3.23 (Debt 21.70b / totalStockholderEquity, last quarter 6.72b)
Debt / EBITDA = 2.01 (Net Debt 17.58b / EBITDA 8.73b)
Debt / FCF = 2.54 (Net Debt 17.58b / FCF TTM 6.91b)
Total Stockholder Equity = 6.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.69% (Net Income 5.02b / Total Assets 59.84b)
RoE = 80.53% (Net Income TTM 5.02b / Total Stockholder Equity 6.23b)
RoCE = 26.31% (EBIT 7.04b / Capital Employed (Equity 6.23b + L.T.Debt 20.53b))
RoIC = 22.32% (NOPAT 6.18b / Invested Capital 27.69b)
WACC = 4.93% (E(141.93b)/V(163.63b) * Re(5.51%) + D(21.70b)/V(163.63b) * Rd(1.34%) * (1-Tc(0.12)))
Discount Rate = 5.51% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -100.0 | Cagr: -2.93%
[DCF] Terminal Value 84.91% ; FCFF base≈6.26b ; Y1≈5.49b ; Y5≈4.47b
[DCF] Fair Price = 510.3 (EV 135.19b - Net Debt 17.58b = Equity 117.61b / Shares 230.5m; r=6.0% [WACC]; 5y FCF grow -15.11% → 3.0% )
EPS Correlation: -30.56 | EPS CAGR: -2.75% | SUE: -0.08 | # QB: 0
Revenue Correlation: 74.01 | Revenue CAGR: 8.52% | SUE: 0.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=7.24 | Chg7d=+0.003 | Chg30d=+0.034 | Revisions Net=+1 | Analysts=17
EPS current Year (2026-12-31): EPS=29.90 | Chg7d=-0.006 | Chg30d=+0.023 | Revisions Net=+1 | Growth EPS=+39.1% | Growth Revenue=+5.4%
EPS next Year (2027-12-31): EPS=31.89 | Chg7d=+0.002 | Chg30d=+0.010 | Revisions Net=+2 | Growth EPS=+6.7% | Growth Revenue=+4.9%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.4% (Discount Rate 7.9% - Earnings Yield 3.5%)
[Growth] Growth Spread = +1.7% (Analyst 6.1% - Implied 4.4%)